Press Releases

COLUMBIA, S.C., Nov. 5, 2019 /PRNewswire/ -- Open enrollment for the Health Insurance Marketplace in South Carolina runs from Nov. 1 through Dec. 15. This year,

Read more...

SILVER SPRING, Md., Nov. 5, 2019 /PRNewswire/ -- Today, the U.S. Food and Drug Administration authorized marketing of a test to detect human i

Read more...

ATLANTA, Nov. 5, 2019 /PRNewswire/ -- Open enrollment for the Health Insurance Marketplace in Georgia runs from Nov. 1 through Dec. 15. This year,

Read more...

CHICAGO, Nov. 5, 2019 /PRNewswire/ -- Beginning Nov. 1 through Dec. 15, Illinois residents may select Amb

Read more...

RESTON, Va., Nov. 5, 2019 /PRNewswire/ -- Amen Clinics Washington, D.C. is now offering several different type

Read more...

VANCOUVER, British Columbia, Nov. 5, 2019 /PRNewswire/ -- Core One Labs Inc. (CSE: COOL), (OTCQX: CLABF), (Frankfurt: LD6, WKN: A14XHT) ("COOL" or the "Company") is issuing this news release to clarify the terms of its definitive agreement to acquire Rainy Daze Cannabis, which was announced on November 4, 201

Read more...

CINCINNATI, Nov. 5, 2019 /PRNewswire/ -- Patient engagement pioneer and 30-year point-of-care marketing leader PatientPoint® dominated the 2019

Read more...

LARGO, Fla., Nov. 5, 2019 /PRNewswire/ -- Men's Liberty™ is sharing the top tips from their users after a diabetes diagnosis and the preferred solution to

Read more...

NEW YORK, Nov. 5, 2019 /PRNewswire/ -- Montefiore Medicine's Board of Trustees announced today that Dr. Philip O. Ozuah has been named the next Chief Executive Officer of Montefiore Medicine, the umbrella organization for Montefiore Health System (MHS) and Albert Einstein College of Medicine. As CEO, Dr. Ozuah will lead Montefiore Medicine's next phase of growth and evol

Read more...

LAS VEGAS and MARLBOROUGH, Mass., Nov. 5, 2019 /PRNewswire/ -- Today, Boston Scientific (NYSE: BSX) announced positive data for two devices within the peripheral drug-eluting product portfolio during separate late-breaking clinical trial presentations at Vascular InterVentional Advances (VIVA) meeting in Las Vega

Read more...